China Universal Asset Management Co., Ltd. 89bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,900 shares of ETNB stock, worth $134,608. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,900
Previous 17,900
-0.0%
Holding current value
$134,608
Previous $208,000
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$94.8 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$55.5 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$49.9 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$47.4 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$41.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $350M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...